ALKERMES | ALKS - 市值

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 7.02B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	市值	更改		日
AbbVie	USD 384.69B		19.14B	2026-03
Acadia Pharmaceuticals	USD 3.8B		724M	2026-03
ALKERMES	USD 5.88B		1.26B	2026-03
Amgen	USD 189.89B		13.64B	2026-03
Biogen	USD 26.9B		1.09B	2026-03
BioMarin Pharmaceutical	USD 10.86B		553M	2026-03
Bristol-Myers Squibb	USD 123.83B		14.02B	2026-03
Coherus Biosciences	USD 172M		19M	2025-12
Eli Lilly	USD 869.02B		146.97B	2026-03
Gilead Sciences	USD 172.99B		20.71B	2026-03
Heron Therapeutics	USD 238M		7M	2025-12
Ionis Pharmaceuticals	USD 12.46B		356M	2026-03
J&J	USD 579.15B		78.91B	2026-03
Malin Corporation	EUR 142.92M		19.65M	2026-02
Merck	USD 297.1B		35.84B	2026-03
Nektar Therapeutics	USD 11.91B		11.05B	2026-06
Neurocrine Biosciences	USD 13.25B		890M	2026-03
Otsuka Holdings	JPY 5.98T		1.16T	2026-03
Ovoca Bio	EUR 6.12M		4.93M	2026-04
Pfizer	USD 153.81B		12.24B	2026-03
Regeneron Pharmaceuticals	USD 81.68B		560M	2026-03
Vertex Pharmaceuticals	USD 113.58B		1.44B	2026-03